Collagen peptides are no longer confined to beauty positioning. In 2026, the most commercially relevant opportunities—particularly in Europe—sit at the intersection of sports recovery, joint mobility, and active aging.
For B2B brands, this shift reflects a deeper structural change. Collagen is moving from a trend-driven ingredient to a functional component embedded in performance, mobility, and longevity routines.
At Klee MUS, we see this transition clearly across formulation strategies and partner demand. The next generation of collagen products is not built around appearance claims—it is built around movement, resilience, and consistency.
Collagen is no longer just about looking better. It is about staying active, training consistently, and supporting long-term physical function.
From beauty-first to performance-led positioning
Collagen’s initial success came from beauty-from-within narratives. While still relevant, that positioning has become highly saturated.
In contrast, performance-led positioning offers:
- stronger differentiation
- clearer functional relevance
- broader consumer reach
The category shift in 2026
Collagen is evolving:
- from aesthetic outcomes → to functional outcomes
- from short-term consumption → to habitual daily use
- from single benefit products → to multi-system formulations
This aligns with how research has evolved. Recent systematic reviews and meta-analyses increasingly evaluate collagen peptides in the context of:
- musculoskeletal health
- connective tissue adaptation
- recovery processes
- body composition (with exercise)
For B2B brands, this creates a stronger, more defensible narrative—one grounded in real physiological roles, not just consumer perception.
Europe: high potential, strict boundaries
Europe offers strong demand—but operates under strict regulatory conditions.
The key regulatory facts:
- EFSA reviewed collagen hydrolysate and joint health claims in 2011
- It concluded that a cause-and-effect relationship was not established
- Regulation (EU) No 379/2012 formally rejected the claim
What this means for brands
There is a critical distinction between:
- scientific evidence
- authorised claims
In practice:
Allowed (B2B / educational context):
- discussing research findings
- positioning collagen in formulation strategies
- describing mechanisms of interest
Restricted (consumer-facing):
- explicit joint-health claims for collagen
- disease-related or therapeutic claims
- implied clinical outcomes
Strategic compliance approach
Leading European brands are not avoiding collagen—they are refining how they use it.
They focus on:
- structure-based positioning (connective tissue, mobility)
- routine-based benefits (daily use, recovery support)
- co-ingredient strategies
A key example:
- Vitamin C has an authorised claim:
→ contributes to normal collagen formation
This allows brands to build compliant musculoskeletal narratives without overstating collagen itself.
Sports recovery: a key growth driver
Sports recovery is one of the most important expansion areas for collagen peptides.
This is not because collagen replaces:
- protein
- carbohydrates
- recovery nutrition fundamentals
Instead, it plays a complementary role.
Where collagen fits
Collagen peptides are increasingly positioned as:
- connective tissue support ingredients
- recovery-quality enhancers
- contributors to structural adaptation
What research shows
Studies report:
- improvements in recovery-related performance markers
- reductions in muscle damage biomarkers
- benefits when combined with structured training
Importantly, these outcomes are:
- context-dependent
- linked to exercise
- not universal across all users
B2B positioning takeaway
Avoid:
- “enhances muscle recovery”
Use:
- supports recovery routines
- complements training adaptation
- contributes to structural resilience
This positions collagen correctly within a system, not as a standalone solution.
Recovery beyond muscle: a structural advantage
Traditional sports nutrition focuses heavily on muscle.
Collagen introduces a broader perspective.
Structural systems supported
- tendons
- ligaments
- cartilage
- extracellular matrix
These systems determine:
- load tolerance
- injury risk
- long-term training consistency
Why this matters commercially
Many consumers do not stop training due to muscle fatigue.
They stop due to:
- joint discomfort
- tendon strain
- recurring injuries
This creates a strong positioning opportunity:
- “stay consistent”
- “train without interruption”
- “support long-term performance”
For B2B brands, this is a clear differentiator vs protein products.
Joint mobility: the core use case
Joint mobility remains the most established collagen positioning.
Evidence direction
Clinical trials and reviews suggest:
- reduced activity-related discomfort
- improved functional movement
- enhanced joint stability markers
While not sufficient for authorised claims in Europe, this body of evidence supports strong B2B-level positioning and formulation strategy.
Why mobility resonates
Mobility is:
- relevant across demographics
- aligned with ageing populations
- easy to translate into daily benefits
Practical consumer framing
Instead of clinical language, mobility should be expressed as:
- moving comfortably
- maintaining independence
- staying active over time
This aligns with both:
- consumer expectations
- regulatory boundaries
Active ageing: a growing commercial layer
One of the most important macro trends influencing collagen is active aging.
Europe has:
- an ageing population
- high interest in maintaining mobility
- increasing demand for functional nutrition
Where collagen fits
Collagen supports positioning around:
- long-term movement quality
- musculoskeletal maintenance
- daily function and independence
B2B opportunity
Products can target:
- 40+ active consumers
- preventative wellness users
- mobility-focused segments
This expands collagen beyond:
- beauty
- sports
Into a lifelong-use ingredient category.
Reframing “metabolic support”
“Metabolic support” is widely used—but often incorrectly.
For collagen, a more accurate framing is:
- body composition support
- lean-mass maintenance
- exercise-linked outcomes
What the science indicates
Studies suggest:
- increases in fat-free mass
- reductions in fat mass (with training)
- improvements in musculoskeletal systems
However:
- effects are indirect
- dependent on exercise
- not equivalent to metabolic enhancement
Better positioning
Avoid:
- “boosts metabolism”
- “supports weight loss”
Use:
- supports active lifestyle goals
- complements training-based body composition strategies
- fits within performance routines
This ensures:
- credibility
- compliance
- long-term brand trust
Formulation strategy: where real value is created
In 2026, differentiation comes from formulation—not inclusion.
Key formulation principles
1. System-based design
- collagen should be part of a broader functional system
2. Regulatory-aware formulation
- include ingredients with authorised claims where possible
3. Synergy matters
- vitamin C → collagen formation
- vitamin D → musculoskeletal support
- minerals → structural health
4. Ingredient quality
- peptide specificity
- traceability
- consistency
B2B implication
Buyers are increasingly evaluating:
- formulation logic
- scientific rationale
- compliance readiness
Not just ingredient presence.
Delivery formats: matching real usage
Collagen’s versatility is a major advantage—but format must align with use.
Format mapping
Powders
- ideal for daily routines
- strong in sports recovery
Stick packs
- convenient and portable
- good for on-the-go users
Capsules
- simple, compliance-friendly
- appeal to general wellness users
RTDs
- premium positioning
- lifestyle integration
Key success factor
The format must reinforce the moment of use.
When aligned:
- adherence improves
- repeat purchase increases
- product value becomes clearer
The evolving collagen consumer
The collagen consumer in Europe has diversified.
Key segments
- fitness and gym users
- endurance athletes
- active ageing consumers
- wellness-focused professionals
What they expect
- science-backed products
- transparency
- realistic benefits
- convenient formats
B2B takeaway
Segmentation is critical.
Different products should target:
- recovery
- mobility
- ageing
- body composition
Collagen is flexible—but messaging must stay focused.
Final perspective
Collagen peptides in 2026 are no longer defined by beauty.
The strongest opportunities in Europe are:
- sports recovery
- joint mobility
- active ageing
- body composition–adjacent positioning
Winning brands will:
- avoid overpromising
- build evidence-based formulations
- align with EU regulations
- focus on real user needs
Collagen does not need exaggerated claims. It delivers the most value when positioned where it is strongest: supporting movement, consistency, and long-term physical function.
Build your next collagen concept with Klee MUS
At Klee MUS, we help brands turn collagen science into compliant, market-ready products for Europe—focused on sports recovery, joint mobility, and active ageing.
Our essentide® collagen peptides are designed for flexible formulation across powders, capsules, and functional beverages, with:
- high protein content (>90%)
- excellent solubility and neutral taste
- suitability for multi-benefit, daily-use concepts
Explore essentide® and start building your next collagen concept with Klee MUS.
References
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). (2011). Scientific opinion on the substantiation of a health claim related to collagen hydrolysate and maintenance of joint health pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal, 9(7), 2291. https://doi.org/10.2903/j.efsa.2011.2291
European Commission. (n.d.). EU register of nutrition and health claims made on foods. Retrieved April 20, 2026, from https://food.ec.europa.eu/food-safety/labelling-and-nutrition/nutrition-and-health-claims/eu-register-health-claims_en
European Commission. (2012). Commission Regulation (EU) No 379/2012 of 3 May 2012 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health. Official Journal of the European Union. https://eur-lex.europa.eu/eli/reg/2012/379/oj
European Commission. (n.d.). Vitamin C contributes to normal collagen formation for the normal function of cartilage (ID 130, 131, 132, 134, 136). EU Register of Nutrition and Health Claims. Retrieved April 20, 2026, from https://ec.europa.eu/food/food-feed-portal/screen/health-claims/eu-register/details/POL-HC-6503
Moya, J., et al. (2025). The effects of type I collagen hydrolysate supplementation on bones, muscles, and joints: A systematic review. Orthopedic Reviews. https://orthopedicreviews.openmedicalpublishing.org/article/129086
Zdzieblik, D., Oesser, S., Baumstark, M. W., Gollhofer, A., & König, D. (2024). The impact of collagen peptide supplementation in combination with exercise on body composition and musculoskeletal outcomes in healthy adults: A systematic review and meta-analysis. Sports Medicine. https://doi.org/10.1007/s40279-024-02079-0
de Miranda, R. B., et al. (2026). Collagen supplementation for skin and musculoskeletal health: An umbrella review. Aesthetic Surgery Journal Open Forum. https://doi.org/10.1093/asjof/ojag018
Jerger, J., et al. (2024). Reduction in systemic muscle stress markers after exercise-induced muscle damage following concurrent training and supplementation with specific collagen peptides. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2024.1384112
Jendricke, P., et al. (2023). Influence of specific collagen peptides and 12-week concurrent training on recovery-related biomechanical characteristics following exercise-induced muscle damage: A randomized controlled trial. Frontiers in Nutrition.https://doi.org/10.3389/fnut.2023.1266056